Table 1. Characteristics of eligible studies included in the meta-analysis.
First author | Year | Country | Ethnicity | Sample size (Case/Control) | MI | Control | MAF | HWE of control | ||||
GG | GT | TT | GG | GT | TT | |||||||
Shimasaki et al [15] | 1998 | Japan | Asian | 285/607 | 225 | 59 | 1 | 526 | 80 | 1 | 0.068 | 0.254 |
Hibi et al [16] | 1998 | Japan | Asian | 226/357 | 189 | 32 | 5 | 295 | 62 | 0 | 0.087 | 0.072 |
Cai et al [17] | 1998 | Australia | Caucasian | 95/478 | 54 | 35 | 6 | 244 | 197 | 37 | 0.283 | 0.751 |
Poirier et al [18] | 1999 | France | Caucasian | 368/421 | 163 | 156 | 49 | 148 | 219 | 54 | 0.388 | 0.051 |
Poirier et al [18] | 1999 | Northern Ireland | Caucasian | 163/155 | 55 | 76 | 32 | 58 | 72 | 25 | 0.394 | 0.738 |
Hingorani et al [19] | 1999 | United Kingdom | Caucasian | 249/183 | 97 | 107 | 45 | 86 | 81 | 16 | 0.309 | 0.617 |
Cai et al [20] | 1999 | Australia | Caucasian | 306/457 | 134 | 137 | 35 | 220 | 182 | 55 | 0.319 | 0.072 |
Song et al [21] | 2000 | China | Asian | 114/104 | 89 | 18 | 7 | 90 | 13 | 1 | 0.072 | 0.501 |
Wang et al [22] | 2001 | Taiwan | Asian | 114/218 | 97 | 17 | 0 | 177 | 38 | 3 | 0.101 | 0.560 |
Gardemann et al [23] | 2002 | Germany | Caucasian | 1277/533 | 565 | 561 | 151 | 256 | 227 | 50 | 0.307 | 0.975 |
Wei et al [24] | 2002 | China | Asian | 51/108 | 40 | 9 | 2 | 98 | 10 | 0 | 0.046 | 0.614 |
Aras et al [25] | 2002 | Turkey | Caucasian | 76/117 | 43 | 28 | 5 | 60 | 48 | 9 | 0.282 | 0.888 |
Qi et al [26] | 2003 | China | Asian | 107/81 | 82 | 16 | 9 | 68 | 13 | 0 | 0.080 | 0.432 |
Schmoelzer et al [27] | 2003 | Austria | Caucasian | 126/248 | 60 | 54 | 12 | 121 | 102 | 25 | 0.306 | 0.609 |
Agema et al [28] | 2004 | Netherlands | Caucasian | 356/574 | 174 | 157 | 25 | 216 | 270 | 88 | 0.389 | 0.811 |
Zhan et al [29] | 2005 | China | Asian | 37/172 | 25 | 12 | 0 | 141 | 31 | 0 | 0.090 | 0.194 |
Antoniades et al [30] | 2005 | Greece | Caucasian | 228/519 | 97 | 99 | 32 | 255 | 217 | 47 | 0.300 | 0.932 |
Yu et al [31] | 2006 | China | Asian | 120/264 | 98 | 22 | 0 | 237 | 26 | 1 | 0.053 | 0.752 |
Chao et al [32] | 2006 | China | Asian | 41/150 | 25 | 11 | 5 | 119 | 29 | 2 | 0.110 | 0.877 |
Jo et al [33] | 2006 | Korea | Asian | 129/803 | 104 | 23 | 2 | 667 | 131 | 5 | 0.088 | 0.600 |
Sampaio et al [34] | 2007 | Brazil | Mixed | 115/104 | 56 | 46 | 13 | 52 | 45 | 7 | 0.284 | 0.509 |
Andrikopoulos et al [35] | 2008 | Greece | Caucasian | 1602/727 | 722 | 701 | 179 | 352 | 297 | 78 | 0.312 | 0.199 |
Odeberg et al [36] | 2008 | Sweden | Caucasian | 318/85 | 179 | 121 | 18 | 43 | 32 | 10 | 0.306 | 0.296 |
Vasilakou et al [37] | 2008 | Greece | Caucasian | 49/161 | 30 | 16 | 3 | 76 | 74 | 11 | 0.298 | 0.212 |
Gluba et al [38] | 2009 | Poland | Caucasian | 278/134 | 140 | 118 | 20 | 62 | 61 | 11 | 0.311 | 0.454 |
Szabó et al [39] | 2009 | Hungary | Caucasian | 118/384 | 39 | 58 | 21 | 200 | 161 | 23 | 0.270 | 0.204 |
Isordia-Salas et al [40] | 2010 | Mexico | Mixed | 180/180 | 104 | 62 | 14 | 134 | 42 | 4 | 0.139 | 0.742 |
Angeline et al [41] | 2010 | India | Asian | 100/100 | 56 | 30 | 14 | 67 | 31 | 2 | 0.175 | 0.462 |
Dafni et al [42] | 2010 | Greece | Caucasian | 204/218 | 83 | 94 | 27 | 108 | 95 | 15 | 0.287 | 0.334 |
Katakami et al [43] | 2010 | Japan | Asian | 226/3593 | 182 | 43 | 1 | 3045 | 533 | 15 | 0.078 | 0.103 |
Gad et al [44] | 2012 | Egypt | Caucasian | 104/101 | 52 | 47 | 5 | 59 | 34 | 8 | 0.248 | 0.333 |
Zigra et al [45] | 2013 | Greece | Caucasian | 107/103 | 50 | 46 | 11 | 50 | 42 | 11 | 0.312 | 0.626 |
Narne et al [46] | 2013 | India | Asian | 73/121 | 42 | 29 | 2 | 84 | 35 | 2 | 0.162 | 0.442 |
Arun et al [47] | 2013 | India | Asian | 287/279 | 213 | 62 | 12 | 190 | 82 | 7 | 0.172 | 0.597 |
MI: Myocardial infarction; MAF: minor allele frequency; HWE: Hardy-Weinberg equilibrium.